Psychedelic Psychiatric Treatment at the FDA

by Rajan Dunne, WVC Board Member

I recently spoke at the FDA’s Part 15 public hearing on the “Considerations for Potential Future Therapeutic Use of Psychedelic Drugs” (September 14, 2026), where I recommended that the FDA require psychiatric oversight when psychedelic drugs are used to treat psychiatric illness. One might assume this was already under consideration. Interestingly, the question of psychiatric oversight has been largely absent from the enthusiastic discussions about commercial rollout.

My recommendation comes from years of working in psychedelic clinical trials, both academic and industry-sponsored. There is a great deal of excitement about bringing these treatments into practice, along with considerable investment in the clinics and infrastructure needed to deliver them. There is much to be hopeful about, though the pressures to expand access and build a new industry are not always aligned with the demands of good psychiatric care.

Administering a drug is not the same as treating an illness. Good psychiatric care requires an understanding of the illness, its natural course, the range of treatment options, and responsibility for the patient over time. Sometimes the appearance of treatment can be mistaken for the thing itself. We should be honest with patients about what we are offering, and what expertise stands behind it. A Trojan horse is not a container of integrity.

There is also the question of how psychiatric treatment fits into the much longer history of psychedelic use. Spiritual, ceremonial, personal, and other uses have their own traditions and purposes, quite apart from psychiatry. If “psychiatric treatment” becomes the only sanctioned pathway, we create incentives to call things psychiatric or medical that aren’t. This risks weakening the integrity of psychiatric care, with potentially serious consequences for patients who have placed their trust in it. It also places other forms of psychedelic use under a framework that is inappropriate for them.

I sincerely hope psychiatry is never put in charge of all psychedelic use. That would be well beyond its rightful scope. But when we’re talking about treating psychiatric illness, as we were at the FDA, psychiatric oversight is appropriate. Its absence from the regulatory discussion deserves consideration.

RAJAN DUNNE Photo

Psychedelics and the Frontiers of Cognitive Liberty

by Annie Oak Harrison, WVC Board Member When Carolyn Garcia, Mariavittoria Mangini and I founded the Women’s Visionary Council in 2007, we understood that we were taking a calculated risk. The Drug War raged around us prosecuting and imprisoning people for possessing psychedelic substances. It wasn’t clear if we would be targeted for creating the […]

Published November 15, 2026

By Womens Visionary Council

The Legacy of Women in Psychedelics (Post Cards)

Presented at: Boom Festival 2025 – Liminal Village, PortugalDate: July 21, 2025Presenter: Kristina Soriano, Executive Director, Women’s Visionary Council As part of this interactive talk at Boom Festival, attendees were invited to reflect on the legacy of women in psychedelics by writing messages to future generations of visionaries. These “Visionary Postcards” are a collective ritual of remembrance and […]

Published September 16, 2025

By Nancy Winslow

Tram Day: Celebrating Psychedelic History and Honoring Women Pioneers

🚋 Tram Day is a new annual holiday created to honor Susi Ramstein — the first woman to take LSD — and to celebrate the powerful, often unacknowledged role of women in this movement. For 40 years, Bicycle Day has celebrated Dr. Hofmann’s famous first trip.But what about the woman who accompanied him — his […]

Published June 5, 2025

By Nancy Winslow

Psychedelic Women Elders Exchange | Women’s Visionary Council

On February 24, 2025, the Women’s Visionary Council hosted the Psychedelic Women Elders Exchange at The Portal Marin. This gathering brought together emerging leaders and visionary elders for an evening of storytelling, dialogue, and intergenerational wisdom-sharing. Speakers:– Rachel Harris, PhD – Psychologist, researcher, and author of Swimming in the Sacred– Maria Mangini, PhD, FNP – […]

Published April 23, 2025

By Nancy Winslow

Women’s Visionary Congress: Honoring the Past, Shaping the Future

Since 2007, the Women’s Visionary Congress (WVC) has been amplifying the voices of women in the psychedelic movement—healers, researchers, activists, artists, and spiritual leaders—who for too long were not being heard. Rooted in intergenerational collaboration and community, WVC provides a space for connection, storytelling, and transformation. In this sizzle reel, you’ll hear from those who […]

Published February 10, 2025

By Nancy Winslow

2024 Giving Tuesday

The 2024 Giving Tuesday on December 3 could make a meaningful impact on the future of the Women’s Visionary Council (WVC). We have been a nonprofit organization since 2008 supported by donors like you. You can make a tax-exempt donation to the WVC at any time via Paypal through Every.org or by sending a check […]

Published November 26, 2024

By Annie Oak